Artículo de opinión
Fármacos biosimilares en psoriasis: informe de posicionamiento
The Use of Biosimilar Drugs in Psoriasis: A Position Paper
Leído
7141
Vecesse ha leído el artículo
3097
Total PDF
4044
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 10 | 6 | 16 |
| 2025 5 | 98 | 24 | 122 |
| 2025 4 | 107 | 26 | 133 |
| 2025 3 | 63 | 13 | 76 |
| 2025 2 | 85 | 28 | 113 |
| 2025 1 | 57 | 22 | 79 |
| 2024 12 | 41 | 23 | 64 |
| 2024 11 | 56 | 49 | 105 |
| 2024 10 | 36 | 34 | 70 |
| 2024 9 | 48 | 16 | 64 |
| 2024 8 | 48 | 51 | 99 |
| 2024 7 | 51 | 24 | 75 |
| 2024 6 | 69 | 35 | 104 |
| 2024 5 | 43 | 25 | 68 |
| 2024 4 | 54 | 27 | 81 |
| 2024 3 | 39 | 31 | 70 |
| 2024 2 | 36 | 32 | 68 |
| 2024 1 | 38 | 27 | 65 |
| 2023 12 | 52 | 13 | 65 |
| 2023 11 | 54 | 29 | 83 |
| 2023 10 | 59 | 29 | 88 |
| 2023 9 | 60 | 25 | 85 |
| 2023 8 | 46 | 13 | 59 |
| 2023 7 | 64 | 32 | 96 |
| 2023 6 | 60 | 20 | 80 |
| 2023 5 | 60 | 22 | 82 |
| 2023 4 | 31 | 34 | 65 |
| 2023 3 | 47 | 18 | 65 |
| 2023 2 | 53 | 27 | 80 |
| 2022 1 | 46 | 33 | 79 |
| 2022 12 | 70 | 33 | 103 |
| 2022 11 | 47 | 33 | 80 |
| 2022 10 | 57 | 46 | 103 |
| 2022 9 | 52 | 47 | 99 |
| 2022 8 | 52 | 60 | 112 |
| 2022 7 | 59 | 48 | 107 |
| 2022 6 | 28 | 28 | 56 |
| 2022 5 | 46 | 49 | 95 |
| 2022 4 | 59 | 48 | 107 |
| 2022 3 | 30 | 56 | 86 |
| 2022 2 | 39 | 43 | 82 |
| 2021 1 | 67 | 42 | 109 |
| 2021 12 | 29 | 56 | 85 |
| 2021 11 | 62 | 47 | 109 |
| 2021 10 | 48 | 56 | 104 |
| 2021 9 | 46 | 40 | 86 |
| 2021 8 | 53 | 26 | 79 |
| 2021 7 | 39 | 24 | 63 |
| 2021 6 | 52 | 40 | 92 |
| 2021 5 | 38 | 27 | 65 |
| 2021 4 | 117 | 99 | 216 |
| 2021 3 | 63 | 37 | 100 |
| 2021 2 | 72 | 30 | 102 |
| 2020 1 | 43 | 35 | 78 |
| 2020 12 | 49 | 37 | 86 |
| 2020 11 | 39 | 29 | 68 |
| 2020 10 | 58 | 19 | 77 |
| 2020 9 | 59 | 31 | 90 |
| 2020 8 | 46 | 22 | 68 |
| 2020 7 | 53 | 16 | 69 |
| 2020 6 | 56 | 22 | 78 |
| 2020 5 | 46 | 60 | 106 |
| 2020 4 | 55 | 20 | 75 |
| 2020 3 | 51 | 28 | 79 |
| 2020 2 | 20 | 6 | 26 |
| 2020 1 | 4 | 15 | 19 |
| 2019 12 | 8 | 6 | 14 |
| 2019 11 | 4 | 9 | 13 |
| 2019 10 | 0 | 12 | 12 |
| 2019 9 | 11 | 6 | 17 |
| 2019 8 | 4 | 4 | 8 |
| 2019 7 | 5 | 10 | 15 |
| 2019 6 | 4 | 42 | 46 |
| 2019 5 | 8 | 163 | 171 |
| 2019 4 | 4 | 70 | 74 |
| 2019 3 | 0 | 15 | 15 |
| 2019 2 | 5 | 9 | 14 |
| 2019 1 | 4 | 11 | 15 |
| 2018 12 | 4 | 27 | 31 |
| 2018 11 | 6 | 27 | 33 |
| 2018 10 | 2 | 4 | 6 |
| 2018 9 | 6 | 5 | 11 |
| 2018 8 | 0 | 7 | 7 |
| 2018 7 | 0 | 12 | 12 |
| 2018 6 | 0 | 12 | 12 |
| 2018 5 | 0 | 17 | 17 |
| 2018 4 | 1 | 14 | 15 |
| 2018 3 | 4 | 10 | 14 |
| 2018 2 | 35 | 13 | 48 |
| 2018 1 | 36 | 10 | 46 |
| 2017 12 | 40 | 19 | 59 |
| 2017 11 | 37 | 16 | 53 |
| 2017 10 | 30 | 17 | 47 |
| 2017 9 | 25 | 27 | 52 |
| 2017 8 | 28 | 10 | 38 |
| 2017 7 | 25 | 12 | 37 |
| 2017 6 | 38 | 25 | 63 |
| 2017 5 | 34 | 31 | 65 |
| 2017 4 | 12 | 15 | 27 |
| 2017 3 | 4 | 39 | 43 |
| 2017 2 | 7 | 12 | 19 |
| 2016 1 | 3 | 8 | 11 |
| 2016 12 | 8 | 9 | 17 |
| 2016 11 | 15 | 16 | 31 |
| 2016 10 | 23 | 20 | 43 |
| 2016 9 | 0 | 17 | 17 |
| 2016 8 | 1 | 14 | 15 |
| 2016 7 | 10 | 4 | 14 |
| 2016 6 | 14 | 15 | 29 |
| 2016 5 | 15 | 2 | 17 |
| 2016 4 | 11 | 3 | 14 |
| 2016 3 | 12 | 1 | 13 |
| 2016 2 | 16 | 9 | 25 |
| 2015 1 | 12 | 1 | 13 |
| 2015 12 | 10 | 2 | 12 |
| 2015 11 | 10 | 7 | 17 |
| 2015 10 | 0 | 7 | 7 |
| 2015 9 | 0 | 10 | 10 |
| 2015 8 | 0 | 1 | 1 |
| 2015 7 | 9 | 8 | 17 |
| 2015 6 | 9 | 4 | 13 |
| 2015 5 | 20 | 58 | 78 |
Mostrar todo
